Companies tied to Robert F Kennedy Jr’s Make America Healthy Again movement are positioned to gain from a regulatory overhaul at the FDA. A two‑day panel voted to broaden public access to a handful of peptides, despite staff objections, opening a multibillion‑dollar opportunity for pharmacies, telehealth providers and drugmakers.

Key beneficiaries include Enhanced Group, a telehealth firm whose investors feature Donald Trump Jr., and Olympia Pharmaceuticals of Florida, which has contributed to a Maha‑aligned political action committee. Both firms are preparing to sell peptides, and their founders have appeared at Maha events, raising concerns about conflicts of interest.

Theши movement also supports psychedelic therapies and wearable health tech. The FDA is set to expand access to psilocybin and other psychedelics in September, while guidance for wellness devices now exempts wrist‑worn trackers from medical‑device regulations, giving companies like Whoop and Definium an advantage.

Investor interest is growing, with Finn Kennedy seeking to raise $100 million for a fund targeting Maha businesses across healthcare, AI and consumer health, though the amount secured remains unclear.